Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Q Zheng, IA Cox, JA Campbell, Q Xia… - ERJ open …, 2022 - Eur Respiratory Soc
Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Q Zheng, IA Cox, JA Campbell, Q Xia… - ERJ open …, 2022 - pubmed.ncbi.nlm.nih.gov
Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Q Zheng, IA Cox, JA Campbell, Q Xia, P Otahal… - ERJ Open …, 2022 - europepmc.org
Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Q Zheng, IA Cox, JA Campbell, Q Xia… - ERJ Open …, 2022 - eprints.qut.edu.au
Background: There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
[PDF][PDF] Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Q Zheng, IA Cox, JA Campbell, Q Xia, P Otahal… - 2022 - figshare.utas.edu.au
Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
[HTML][HTML] Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Q Zheng, IA Cox, JA Campbell, Q Xia… - ERJ Open …, 2022 - Eur Respiratory Soc
Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
[HTML][HTML] Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Q Zheng, IA Cox, JA Campbell, Q Xia, P Otahal… - ERJ Open …, 2022 - ncbi.nlm.nih.gov
Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Q Zheng, IA Cox, JA Campbell, Q Xia, P Otahal… - ERJ Open …, 2022 - europepmc.org
Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
[PDF][PDF] Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Q Zheng, IA Cox, JA Campbell, Q Xia, P Otahal - figshare.utas.edu.au
Background: There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …